Assessing Cost-Effectiveness And Key Value Drivers of Adjuvant Triglyceride Lowering Therapy In Management of Patients with A Rare Genetic Syndrome

Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.891
https://www.valueinhealthjournal.com/article/S1098-3015(17)31225-1/fulltext
Section Title : Disease-Specific Studies
Section Order : 850
First Page : A555
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31225-1&doi=10.1016/j.jval.2017.08.891
HEOR Topics :
Tags :
Regions :